Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human iPS cell–derived hematopoietic progenitor cells induce T-cell anergy in in vitro–generated alloreactive CD8+ T cells

18 May 2013

Abstract excerpt

Human induced pluripotent stem cells (iPSCs) have emerged as an alternative source of pluripotent stem cells that can be used for tissue regeneration in place of the controversial human embryonic stem cells. However, immunologic knowledge about iPSC derivatives remains enigmatic. Here, we characterized human iPS-derived CD34(+) hematopoietic progenitor cells (HPCs). These HPCs poorly express major...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Organ and Tissue Transplantation Research
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23687092
DOI: 10.1182/blood-2012-11-467753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human iPS cell–derived hematopoietic progenitor cells induce T-cell anergy in in vitro–generated alloreactive CD8+ T cellsPMID 23687092Read ↗

Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunitySemantic proximity Read ↗

iPSC modification strategies to induce immune toleranceSemantic proximity Read ↗

Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockoutSemantic proximity Read ↗

Generation of universal and hypoimmunogenic human pluripotent stem cellsSemantic proximity Read ↗

Roadblocks in the Path of iPSC to the ClinicSemantic proximity Read ↗

Pluripotent Stem Cells: Immune to the Immune System?Semantic proximity Read ↗

Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell ImmunitySemantic proximity Read ↗

Concise Review: Immune Recognition of Induced Pluripotent Stem CellsSemantic proximity Read ↗

Human Embryonic Stem Cells Possess Immune‐Privileged PropertiesSemantic proximity Read ↗

Translational Prospects for Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editingSemantic proximity Read ↗

Generation of hypoimmunogenic human pluripotent stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.